FIELD: medicine.
SUBSTANCE: invention relates to method for treatment, prevention and alleviation of testosterone deficit development; or symptoms associated with testosterone deficit in mammalian females. Claimed method includes application of gel containing (wt.%) testosterone 0.1-10; isopropylmyristate 0.1-5 %; ethanol 98 % or less; and thickening agent 0.1-5 % on skin of subject.
EFFECT: convenient method for maintenance of daily reproducible testosterone levels.
8 cl, 5 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADMINISTRATION OF ANDROGENIC STEROIDS TO WOMEN BY NON-ORAL ROUTE | 2000 |
|
RU2234920C2 |
| TRANSDERMAL PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE AGENTS | 2010 |
|
RU2639087C2 |
| AGENT BASED ON DEHYDROEPIANDROSTERONE, METHOD FOR USE THEREOF | 2014 |
|
RU2592370C9 |
| AGENT FOR CORRECTING MENSTRUAL IRREGULARITIES, MENOPAUSAL DISORDERS | 2022 |
|
RU2801514C1 |
| INTERRUPTED HORMONE-SUBSTITUTION THERAPY WITH LOW ESTROGEN DOSAGES | 2000 |
|
RU2245713C2 |
| PREPARATION AND METHOD FOR THE TREATMENT OF ANDROGEN DEFICIENCY IN WOMEN, ENTOMOLOGICAL CONTAINING PROTEINS | 2015 |
|
RU2577225C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| METHOD FOR THERAPEUTIC TREATMENT OF EXTRAUTERINE PROLIFERATION OF ENDOMETRIAL TISSUE CHRONIC PAIN IN PELVIS REGION CAUSED BY THEREOF AND FALLOPIAN TUBES IMPENETRABILITY | 2000 |
|
RU2255759C2 |
| DROSPYRENON FOR REPLACEMENT HORMONOTHERAPY | 2001 |
|
RU2275198C2 |
| DROSPIRENONE FOR HORMONAL REPLACEMENT THERAPY | 2005 |
|
RU2402331C2 |
